Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients
Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has been observed to vary in its degree of symptoms. One of the most important clinical manifestations is pneumonia...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Termedia Publishing House
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/76f5289ab74b4934bde3bedbbad502ab |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|